ChannelAdvisor IPO ...
Health Care: Drugs
Corcept Therapeutics Inc. (CORT: NASDAQ)
$1.82 0.02 | 1.11%
05/23/13 - 03:11 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 1.80 |
| 52 Week High | 4.55 |
| 52 Week Low | 1.27 |
| Avg. Daily Vol. (Mil) | 0.17 |
| Beta (3 year) | 1.30 |
| Share Related Items | |
| Mkt Cap (Mil) | 179.67 |
| Shares Out (Mil) | 99.81 |
| Float (Mil) | 53.60 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 10.00 |
| Current Ratio | 10.20 |
| LT Debt/ Equity | 0.57 |
| Total Debt / Equity | 0.64 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 35.76 |
| Price/Book | 3.52 |
| Price/Cash Flow | -3.80 |
| Per Share Data | |
| Earnings | -0.40 |
| Sales | 0.05 |
| Book Value | 0.51 |
| Cash Flow | -0.47 |
| Business Summary | |
|---|---|
| Corcept Therapeutics Inc. is engaged in the discovery and development of drugs for the treatment of severe metabolic and psychiatric disorders. | |
| General Information | |
| 149 Commonwealth Drive
Menlo Park, CA 94025 |
|
| www.corcept.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 17 | |
| CEO: Joseph K. Belanoff,M.D. | |
| Short Interest | |
| Current Month (Mil) | 2.89 |
| Previous Month (Mil) | 3.00 |
| Short Interest Ratio (Days) | 21.80 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -56.90 |
| Return on Investments | -62.00 |
| Profitability | |
| Gross Margin | 97.80 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with CORT
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
Latest CORT Headlines from TheStreet
- 5 Stocks Setting Up to Break Out 01.25.13 | 01:01 pm
- 3 Stocks Under $2 Spiking Higher 01.03.13 | 03:01 pm
- Short Sellers Are More Bullish About These Hedge Fund Favorites 12.20.12 | 04:12 pm
- 5 Stocks Insiders Are Snapping Up 11.28.12 | 12:11 pm
- Corcept Has Upside Following Drug Approval 02.21.12 | 12:02 pm
- 7 Stocks Under $10 Moving Higher 02.16.12 | 02:02 pm
- These Drugs Stocks Will Win FDA Approval 02.16.12 | 12:02 pm
- Biotech Stock Mailbag: Corcept Therapeutics, Reader Retorts 02.10.12 | 07:02 am
- Play TheStreet's FDA Drug-Approval Contest 01.23.12 | 08:01 am
- 27 Hot Drugs Facing FDA Approval in 2012 12.19.11 | 10:12 am
Press Releases for CORT
- Behind The Success - Research Report On Corcept Therapeutics Inc. And Dyax Corp. - PR Newswire 01.23.13 | 08:01 am
Partner Headlines for CORT
- UPDATE: Piper Jaffray Downgrades Corcept Therapeutics to Neutral Following 1Q13 Earnings Report - Benzinga 05.06.13 | 09:05 am
- 2 $2 Biotech Stocks Insiders Are Buying - Seeking Alpha 03.01.13 | 09:03 am
- 3 Liquid Biotech Stocks With Impressive Growth Projections - Seeking Alpha 08.12.12 | 09:08 am
- Facebook and Nasdaq STILL BATTLING and 3 Headlines Investors are Watching Now - Wall St. Cheat Sheet 07.02.12 | 12:07 pm
- Company News for February 22, 2012 - Corporate Summary - Zacks 02.22.12 | 10:02 am
- UPDATE: Stifel Nicolaus Increases Target to $9 on Concept Therepeutics - Benzinga 02.21.12 | 09:02 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- Upcoming PDUFA Dates for Sub-$5 Stocks - Seeking Alpha 07.05.11 | 09:07 am
- 14 Oversold Stocks With Bearish Options - Seeking Alpha 07.01.11 | 08:07 am
- 10 Undervalued Biotech Stocks With Insider Buying - Seeking Alpha 06.23.11 | 06:06 am
